| 2025-09-29 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale+OE | 10,473 | $64.54 | $675,945.22 | -15.5% | → |
| 2025-09-12 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale+OE | 1,700 | $64.58 | $109,787.19 | -2.9% | → |
| 2025-09-09 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale+OE | 21,000 | $64.56 | $1,355,661.30 | -15.5% | → |
| 2025-09-09 | Baroldi Joseph | EVP, Chief Business Officer | Sale+OE | 11,950 | $62.16 | $742,838.29 | -27.2% | → |
| 2025-09-05 | Baroldi Joseph | EVP, Chief Business Officer | Sale+OE | 250 | $62.00 | $15,500.00 | -0.8% | → |
| 2025-09-05 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 6,000 | $59.60 | $357,580.80 | -6.8% | → |
| 2025-09-03 | KLEIN JOSEPH III | Director | Sale+OE | 28,000 | $60.00 | $1,680,000.00 | -100% | → |
| 2025-09-03 | KLEIN JOSEPH III | Director | Sale+OE | 28,000 | $60.00 | $1,680,000.00 | -100% | → |
| 2025-09-03 | Monia Brett P | Chief Executive Officer | Sale+OE | 203,814 | $60.32 | $12,294,703.00 | -24.5% | → |
| 2025-09-03 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 3,162 | $61.02 | $192,942.71 | -17.4% | → |
| 2025-09-03 | LOSCALZO JOSEPH | Director | Sale+OE | 16,000 | $60.15 | $962,371.20 | -30.6% | → |
| 2025-09-03 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sale+OE | 19,658 | $60.81 | $1,195,420.87 | -15.1% | → |
| 2025-09-03 | Baroldi Joseph | EVP, Chief Business Officer | Sale+OE | 32,800 | $59.34 | $1,946,220.28 | -40.2% | → |
| 2025-09-03 | WENDER JOSEPH H | Director | Sell | 28,000 | $57.58 | $1,612,155.44 | -7.3% | → |
| 2025-09-03 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sale+OE | 89,900 | $60.03 | $5,396,843.39 | -56.2% | → |
| 2025-09-03 | WENDER JOSEPH H | Director | Sell | 28,000 | $57.58 | $1,612,155.44 | -7.3% | → |
| 2025-09-03 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sale+OE | 38,909 | $59.14 | $2,301,263.58 | -17.0% | → |
| 2025-09-02 | Swayze Eric | EVP Research | Sell | 11,130 | $49.67 | $552,861.68 | -12.8% | → |
| 2025-09-02 | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $50.37 | $503,671.00 | -11.2% | → |
| 2025-09-02 | PARSHALL B LYNNE | Director | Sell | 20,000 | $50.91 | $1,018,297.50 | -12.4% | → |
| 2025-08-22 | Diaz Allene M. | Director | Sell | 1,427 | $42.53 | $60,687.17 | -7.2% | → |
| 2025-08-18 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sale+OE | 10,000 | $43.98 | $439,776.00 | -9.7% | → |
| 2025-08-06 | PARSHALL B LYNNE | Director | Sell | 5,000 | $41.93 | $209,646.10 | -2.8% | → |
| 2025-08-05 | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $42.86 | $428,593.00 | -10.1% | → |
| 2025-08-04 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,549 | $42.80 | $408,701.02 | -15.6% | → |
| 2025-07-30 | Monia Brett P | Chief Executive Officer | Sale+OE | 2,432 | $45.00 | $109,440.00 | -1.3% | → |
| 2025-07-11 | Monia Brett P | Chief Executive Officer | Sell | 1,160 | $41.74 | $48,416.20 | -0.6% | → |
| 2025-05-01 | Hayden Michael R | Director | Buy | 15,000 | $31.86 | $477,900.00 | +42.6% | → |
| 2025-04-16 | Birchler Brian | EVP, Corp and Development Ops | Sale+OE | 680 | $28.37 | $19,291.60 | -1.2% | → |
| 2025-04-16 | Baroldi Joseph | EVP, Chief Business Officer | Sale+OE | 3,928 | $28.40 | $111,555.20 | -11.0% | → |
| 2025-04-16 | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sale+OE | 3,016 | $28.36 | $85,533.76 | -21.2% | → |
| 2025-03-11 | Monia Brett P | Chief Executive Officer | Sell | 140 | $32.32 | $4,524.80 | - | → |
| 2025-02-20 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 1,207 | $32.35 | $39,046.45 | -2.1% | → |
| 2025-02-04 | Monia Brett P | Chief Executive Officer | Sell | 38,843 | $31.65 | $1,229,462.52 | -17.7% | → |
| 2025-02-04 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 6,165 | $31.62 | $194,939.15 | -9.7% | → |